Véto-pharma just obtained the EPA federal registration for Amiflex®, a 7-day-flash treatment for varroa mites that has been specially designed for commercial operations.
After years of rigorous R&D, Véto-pharma has obtained federal registration for a unique and innovative amitraz gel formulation that’s specially designed to address the needs of commercial beekeepers.
This 7-day-flash treatment is temperature independent and comes in a tailor-made package to reduce labor costs. Its distinctive versatility allows for use in between honey flows and eliminates the need for a withdrawal period while delivering accurate and controlled dosages.
Amiflex® possesses optimal efficacy and comes in a fast and convenient ‘ready-to-use’ formulation that’s safe for colonies and affordable for beekeepers.
Amiflex is a 7-day treatment that can be used 1-4 times a year. The new gel formulation provides a faster release of amitraz than plastic strip applications, achieving 94% efficacy on the 3rd day of application and 100% on the 7th day in broodless colonies. Amiflex also ensures a quick knock-down of varroa mites in the presence of brood with one or two applications, according to the infestation rate.
Ready to use and guaranteed safety
Amiflex was designed to be non-labor intensive, decreasing preparation and application time, while guaranteeing a high level of safety for honeybees and minimizing the beekeeper’s exposure to the product.
Amiflex has been approved by the EPA and will be available soon to beekeepers in accordance with local state registrations.
In the meantime, you can learn more about Amiflex by visiting the Véto-pharma website:
And read more content on our blog about ways to fight varroa: